Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics, the market leader in pharmaceutical distribution in Sri Lanka, has appointed Dr. Mahesha Ranasoma as its Managing Director, effective April 2, 2025.
For over six decades, Hemas Pharmaceuticals has played a pivotal role in strengthening Sri Lanka’s healthcare sector. Through long-standing partnerships with globally renowned healthcare principles, the company has consistently ensured access to high-quality, safe, and effective healthcare solutions across the country. As a trusted partner of all stakeholders, Hemas remains dedicated to advancing access to innovative healthcare solutions, while upholding the highest standards of quality, compliance, and ethical practice.
“As we continue to expand our leadership position in the healthcare sector, Dr. Ranasoma’s extensive experience and proven ability to lead complex operations across multiple industries will be instrumental to pivot to the future. His purpose-driven leadership style is deeply aligned with Hemas’ values and will play a vital role in strengthening our partnerships, keeping the country’s healthcare needs at the forefront, and driving sustainable, long-term growth,” said Murtaza Esufally, Chairman of Hemas Healthcare.
Dr. Ranasoma brings over 25 years of cross-sector leadership experience in both multinational and local organizations. Prior to joining Hemas Pharmaceuticals, he served as CEO of Global Rubber Industries (GRI) and as Managing Director of Dipped Products PLC under the Hayleys Group. He has also held regional leadership roles, including Country Chairman of Shell Sri Lanka and General Manager of Shell Vietnam, where he led transformational initiatives in growth, innovation, and operational excellence.
“I am honoured to join Hemas Pharmaceuticals at such a dynamic time in the healthcare industry,” said Dr. Mahesha Ranasoma. “Hemas has built a strong reputation for excellence in pharmaceutical distribution and healthcare solutions. I look forward to working with our talented team and esteemed partners to further strengthen our market leadership, enhance accessibility to quality medicines, and contribute meaningfully to the healthcare eco-system.”
Under Dr. Ranasoma’s leadership, Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics will continue to be a trusted partner in delivering innovative and high-quality healthcare to all Sri Lankans.
